shenlian biologyoddsofstraightflush: Swine fever vaccine approved for new veterinary drug registration Securities Times Company e News, Shenlian Biotech (688098) announced on the evening of May 5 that after review by the Ministry of Agriculture and Rural Affairs, the company's Swine fever genetically engineered subunit vaccine (CHO-133D) was approved as a new veterinary drug, and the "New Veterinary Drug Registration Certificate" was issued. theoddsofstraightflush...
Shenlian Biotech: The swine fever vaccine was approved for new veterinary drug registration Securities Times Company News, Shenlian Biotech (688098) announced on the evening of May 5 that after review by the Ministry of Agriculture and Rural Affairs, the company's swine fever genetically engineered subunit vaccine (CHO-133D) was approved as a new veterinary drug and the "New Veterinary Drug Registration Certificate" was issued. This product is a product jointly developed and declared by the company and Beijing Zhonghai Biotechnology Co., Ltd. and other units. It can be used to prevent swine fever.
